AOXG (Aoxing Pharmaceutical Co) EBIT per Share: $0.02 (TTM As of Mar. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aoxing Pharmaceutical Co EBIT per Share?

Aoxing Pharmaceutical Co AOXG EBIT per Share is $0.02 as of Mar. 2017.

Aoxing Pharmaceutical Co's EBIT per Share for the three months ended in Mar. 2017 was $0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2017 was $0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Aoxing Pharmaceutical Co's EBIT per Share or its related term are showing as below:

AOXG's 3-Year EBIT Growth Rate is not ranked *
in the Diversified Financial Services industry.
Industry Median: 15.7
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Aoxing Pharmaceutical Co's EBIT for the three months ended in Mar. 2017 was $0.88 Mil.

Aoxing Pharmaceutical Co  (OTCPK:AOXG) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Aoxing Pharmaceutical Co EBIT per Share Related Terms

Aoxing Pharmaceutical Co EBIT per Share Historical Data

* Premium members only.

The historical data trend for Aoxing Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aoxing Pharmaceutical Co EBIT per Share Chart

Aoxing Pharmaceutical Co Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.13 -0.07 0.14 0.08

Aoxing Pharmaceutical Co Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 -0.02 0.02 0.00 0.01

Aoxing Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Aoxing Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Jun. 2016 is calculated as

EBIT per Share(A: Jun. 2016 )
=EBIT/Shares Outstanding (Diluted Average)
=6.228/75.468
=0.08

Aoxing Pharmaceutical Co's EBIT per Share for the quarter that ended in Mar. 2017 is calculated as

EBIT per Share(Q: Mar. 2017 )
=EBIT/Shares Outstanding (Diluted Average)
=0.878/76.209
=0.01

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $0.02 mean?
Aoxing Pharmaceutical Co (AOXG) has a EBIT per Share of $0.02 as of Mar. 2017. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Aoxing Pharmaceutical Co and its competitors.
Is Aoxing Pharmaceutical Co's EBIT per Share too high?
Aoxing Pharmaceutical Co's current EBIT per Share is $0.02. The Diversified Financial Services industry median EBIT per Share is 15.70. Aoxing Pharmaceutical Co's value of $0.02 is 99.9% below this industry median.
How does Aoxing Pharmaceutical Co's EBIT per Share compare to OWCP and BSPK?
Aoxing Pharmaceutical Co's EBIT per Share of $0.02 can be compared against companies in the Diversified Financial Services industry. The industry median EBIT per Share is 15.70. Aoxing Pharmaceutical Co's value of $0.02 is 99.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Diversified Financial Services company?
The median EBIT per Share among Diversified Financial Services companies is 15.70, based on 198 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aoxing Pharmaceutical Co's current EBIT per Share of $0.02 is 99.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Aoxing Pharmaceutical Co and its competitors. For the Diversified Financial Services industry, the median EBIT per Share is 15.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aoxing Pharmaceutical Co's current EBIT per Share is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aoxing Pharmaceutical Co stock overvalued right now?
Aoxing Pharmaceutical Co (AOXG) has a current EBIT per Share of $0.02. The current EBIT per Share is $0.02 and 99.9% below the Diversified Financial Services industry median of 15.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Aoxing Pharmaceutical Co (AOXG), the current EBIT per Share is $0.02 as of Mar. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aoxing Pharmaceutical Co Business Description

Address Block 25, Flat F, 9th Floor, South Horizons, Apleichau, Hong Kong, HKG
Aoxing Pharmaceutical Co Inc does not have any business operations and is restructuring for a new business model and plans to acquire an operating company via reverse merger.